Structure?activity relationship and in vitro inhibition of human cytochrome CYP2A6 and CYP2A13 by flavonoids

被引:6
|
作者
Boonruang, Supattra [1 ]
Prakobsri, Khanistha [1 ]
Pouyfung, Phisit [2 ]
Prasopthum, Aruna [3 ]
Rongnoparut, Pornpimol [3 ]
Sarapusit, Songklod [4 ,5 ,6 ]
机构
[1] Burapha Univ, Fac Engn, Bioengn Program, Muang, Chonburi, Thailand
[2] Walailak Univ, Sch Publ Hlth, Dept Community Publ Hlth, Thasala, Nakhon Si Thamm, Thailand
[3] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand
[4] Burapha Univ, Fac Sci, Dept Biochem, 169 Long Hard Bangsaen Rd, Muang 20131, Chonburi, Thailand
[5] Burapha Univ, Fac Sci, Res Unit Nat Bioact Cpds Healthcare Prod Dev, 169 Long Hard Bangsaen Rd, Muang 20131, Chonburi, Thailand
[6] Burapha Univ, Fac Sci, Ctr Innovat Chem, Muang, Chonburi, Thailand
关键词
inhibition; flavonoid; kaempferol; myricetin; MECHANISM-BASED INACTIVATION; BIOAVAILABLE FLAVONOIDS; ANTIOXIDANT ACTIVITY; ACTIVE COMPOUNDS; 2A6; TOBACCO; NICOTINE; 2A13; METABOLISM; CARCINOGENS;
D O I
10.1080/00498254.2019.1675101
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cigarette smoking is one of the major risk factors of various diseases including respiratory diseases and lung cancer. While the liver-specific CYP2A6 is associated with the nicotine clearance and smoking addiction, the metabolic activation of the tobacco-specific nitrosamine by lung-specific CYP2A13 can lead to lung tumorigenesis. It has been reported that inhibition of CYP2A6 and CYP2A13 enzymes by flavonoids constituents could be an aids in smoking cessation. This study demonstrates the inhibition activity of kaempferol and myricetin and the structure?function relationship of these two flavonoids and previously isolated flavonoids from Vernonia cinerea and Pluchea indica against both enzymes. Kaempferol could inhibit CYP2A6 with K-ic value of 1.77???0.47 ?M while inhibit CYP2A13 with K-ic value of 0.12???0.01 ?M. Myricetin could inhibit CYP2A6 with K-ic value of 4.06???0.52 ?M while inhibit CYP2A13 with K-ic value of 1.88???0.03 ?M. Molecular docking indicated that CYP2A13 enzyme has strong hydrophobic interaction with ring B of flavonoids compared to CYP2A6 enzyme. The presence of the hydroxyl group at C3 position of ring C and the hydroxyl group at C5? of ring B affected inhibitory activity on both enzymes.
引用
收藏
页码:630 / 639
页数:10
相关论文
共 50 条
  • [41] Transcriptional regulation of the human CYP2A6 gene
    Pitarque, M
    Rodríguez-Antona, C
    Oscarson, M
    Ingelman-Sundberg, M
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (02): : 814 - 822
  • [42] A CYP2A6 haplotype explains a substantial part of CYP2A6 phenotype variation in caucasians
    Haberl, M
    Weil, R
    Fuss, C
    Zanger, UM
    Kerb, R
    Wojnowski, L
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 67 - 67
  • [43] Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity
    Lewis, DFV
    Dickens, M
    Lake, BG
    Eddershaw, PJ
    Tarbit, MH
    Goldfarb, PS
    [J]. TOXICOLOGY, 1999, 133 (01) : 1 - 33
  • [44] Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme
    Rahnasto, M
    Raunio, H
    Poso, A
    Wittekindt, C
    Juvonen, RO
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) : 440 - 449
  • [45] Genetic polymorphism of the human cytochrome CYP2A13 in a French population:: implication in lung cancer susceptibility
    Cauffiez, C
    Lo-Guidice, JM
    Quaranta, S
    Allorge, D
    Chevalier, D
    Cenée, S
    Hamdan, A
    Lhermitte, M
    Lafitte, JJ
    Libersa, C
    Colombel, JF
    Stücker, I
    Broly, F
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 317 (02) : 662 - 669
  • [46] Selective Expression of CYP2A13 in Human Pancreatic α-Islet Cells
    Guo, Yu
    Zhu, Liang-Ru
    Lu, Gang
    Wang, Hui
    Hong, Jun-Yan
    [J]. DRUG METABOLISM AND DISPOSITION, 2012, 40 (10) : 1878 - 1882
  • [47] The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity
    Bojic, Mirza
    Kondza, Martin
    Rimac, Hrvoje
    Benkovic, Goran
    Males, Zeljan
    [J]. MOLECULES, 2019, 24 (17):
  • [48] Cinnamaldehyde Analogs as CYP2A6 Inhibitors: A Structure-Activity Study
    Black, Stephen
    Joseph, Paul
    Higa, Allyson
    Moyeen, Ghina
    Ebisuya, Kara
    Davis, Madison
    Chan, Jeannine
    Harrelson, John
    [J]. FASEB JOURNAL, 2016, 30
  • [49] PharmVar GeneFocus: CYP2A6
    Langlois, Alec W. R.
    Chenoweth, Meghan J.
    Twesigomwe, David
    Scantamburlo, Giada
    Whirl-Carrillo, Michelle
    Sangkuhl, Katrin
    Klein, Teri E.
    Nofziger, Charity
    Tyndale, Rachel F.
    Gaedigk, Andrea
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024,
  • [50] Generation and characterization of a human CYP2A13 transgenic mouse model
    Wei, Yuan
    Zhou, Xin
    Ling, Guoyu
    Zhang, Xiuling
    D'Agostino, Jaime
    Gu, Jun
    Kluetzman, Kerri
    Ding, Xinxin
    Zhang, Qing-Yu
    [J]. DRUG METABOLISM REVIEWS, 2006, 38 : 54 - 54